Oct 22, 2018
This week in our Your Stock, Our Take segment we look at BioSyent Inc. (RX:TSX-V), a specialty pharmaceutical company engaged in developing pharmaceutical and healthcare products. The company has been a micro-cap success story rising from below a $1.00 to the $10.00 range – a listener asks if we still like the stock.

Sign up for the Stock Talk Podcast

Be the first to find out the latest Keystone Financial news, special reports, receive our Stock Talk Podcast, DIY Seminar event info, and Your Stock Our Take videos directly to your inbox for free.